The "ZEB2 Gene Central Hypoventilation Syndrome Congenital Genetic Test" is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the ZEB2 gene, which are linked to Mowat-Wilson Syndrome. This condition is characterized by a range of symptoms, including Hirschsprung disease, distinctive facial features, intellectual disability, and, in some cases, congenital central hypoventilation syndrome (CCHS). CCHS is a serious respiratory disorder that impairs autonomic control of breathing, necessitating lifelong respiratory support during sleep for affected individuals.
This genetic test is crucial for early diagnosis and management of the syndrome, enabling tailored care and interventions that can significantly improve the quality of life for individuals with the condition. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the lab for the presence of specific mutations in the ZEB2 gene.
The cost of the test at DNA Labs UAE is 4400 AED, reflecting the specialized nature of the analysis and the profound impact that the results can have on the management of affected individuals and their families. Early and accurate diagnosis through this test can facilitate appropriate genetic counseling, guide medical management, and help families prepare for the unique needs of individuals with Mowat-Wilson Syndrome.
The SNAP29 Gene Cerebral Dysgenesis, Neuropathy, Ichthyosis, and Palmoplantar Keratoderma (CNSDIP) Syndrome Genetic Test is a specialized diagnostic examination conducted to detect mutations in the SNAP29 gene, which are implicated in the development of CNSDIP syndrome. This rare genetic disorder is characterized by a combination of neurological abnormalities, peripheral nerve problems, skin issues, and distinctive thickening of the skin on the palms of the hands and soles of the feet. Early diagnosis through genetic testing is crucial for managing symptoms and improving the quality of life for affected individuals.
The test, available at DNA Labs UAE, involves analyzing the patient's DNA to identify mutations in the SNAP29 gene that are responsible for the syndrome. The procedure is conducted with utmost precision and confidentiality, ensuring reliable results for patients and their families.
The cost of the SNAP29 Gene CNSDIP Syndrome Genetic Test is set at 4400 AED. This price reflects the comprehensive nature of the test, covering the expenses associated with the sophisticated technology and expertise required to accurately detect the genetic abnormalities associated with the syndrome. Upon completion, the test provides crucial information that can guide treatment options, support planning for healthcare needs, and offer insight into the genetic risk for other family members.
The ERCC6 gene cerebrooculofacioskeletal syndrome type 1 genetic test is a sophisticated diagnostic tool designed to identify mutations in the ERCC6 gene, which are responsible for cerebrooculofacioskeletal syndrome type 1 (COFS1). COFS1 is a rare genetic disorder characterized by developmental delays, microcephaly, impaired facial features, and other systemic abnormalities, affecting the brain, eyes, and skeletal system. Early diagnosis through genetic testing is crucial for managing symptoms and improving the quality of life for affected individuals.
The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in a laboratory setting to detect any genetic abnormalities in the ERCC6 gene. This detailed analysis helps in confirming the diagnosis of COFS1, enabling healthcare providers to devise a tailored management plan for the patient.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test ensures high accuracy and reliability. The cost of the ERCC6 gene cerebrooculofacioskeletal syndrome type 1 genetic test is 4400 AED, reflecting the sophisticated technology and expertise required to conduct such specialized genetic testing. This investment is pivotal for affected families seeking answers and a clear direction for the care and support of their loved ones with COFS1.
The ERCC1 Gene Cerebrooculofacioskeletal Syndrome Type 4 Genetic Test is a specialized diagnostic procedure aimed at detecting mutations in the ERCC1 gene, which are associated with Cerebrooculofacioskeletal Syndrome Type 4 (COFS4). This rare genetic disorder is characterized by developmental delays, microcephaly, impaired cranial nerve function, and other physical abnormalities. The test is crucial for early diagnosis and management of the condition, allowing for tailored care and support for affected individuals.
Performed at DNA Labs UAE, a leading facility in genetic testing, this test offers a comprehensive analysis of the ERCC1 gene to identify potential mutations. The cost of the test is set at 4400 AED, reflecting the sophisticated technology and expertise required to accurately diagnose this complex condition. By opting for this test, patients and their families can gain valuable insights into the genetic underpinnings of COFS4, facilitating informed decisions about treatment and care.
The TFAP2B Gene Char Syndrome Genetic Test is a specialized diagnostic tool used to detect mutations in the TFAP2B gene, which is implicated in Char Syndrome, a rare genetic disorder. Char Syndrome is characterized by distinctive facial features, heart defects, and hand anomalies. The test involves analyzing the patient's DNA to identify any genetic alterations in the TFAP2B gene that might lead to the syndrome.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the process ensures accuracy and reliability in results, providing crucial information for the diagnosis, management, and genetic counseling of affected individuals and their families. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to perform this detailed genetic analysis. This test is essential for families with a history of Char Syndrome, offering them insights into their genetic makeup and aiding in making informed health and family planning decisions.
The CHD7 Gene CHARGE Syndrome Genetic Test is a specialized diagnostic assessment conducted to identify mutations in the CHD7 gene, which are commonly associated with CHARGE Syndrome. CHARGE Syndrome is a complex genetic condition that affects several body systems, leading to a wide range of symptoms such as congenital heart defects, growth retardation, hearing loss, and developmental delays. The genetic test for CHARGE Syndrome is crucial for early diagnosis and intervention, allowing for tailored management and care plans for affected individuals.
Performed at DNA Labs UAE, this test involves analyzing the patient's DNA to look for specific mutations in the CHD7 gene that are linked to the syndrome. A positive test result can confirm the diagnosis of CHARGE Syndrome, enabling healthcare providers to offer appropriate genetic counseling to families and to devise a comprehensive treatment strategy for the patient.
The cost of the CHD7 Gene CHARGE Syndrome Genetic Test at DNA Labs UAE is 4400 AED. This price includes the full process of collecting the DNA sample, conducting the genetic analysis, and providing a detailed report of the findings. It's important for patients and families considering this test to consult with their healthcare provider to understand the implications of the results and to discuss any concerns they may have regarding the syndrome and the testing process.
The PIGL Gene CHIME Syndrome Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the PIGL gene, which are associated with CHIME Syndrome. CHIME Syndrome is a rare genetic disorder characterized by a range of symptoms including colobomas (defects in the eye), heart defects, atresia of the choanae, intellectual disability, and ear abnormalities. The test is crucial for early diagnosis and management of the syndrome, helping healthcare providers tailor appropriate treatments and interventions for affected individuals.
The genetic test involves analyzing the patient's DNA to look for specific mutations in the PIGL gene that are known to cause CHIME Syndrome. This is done through a blood sample or other tissue samples from the patient, which are then processed and analyzed in the state-of-the-art facilities at DNA Labs UAE.
The cost of the PIGL Gene CHIME Syndrome Genetic Test at DNA Labs UAE is 4400 AED. This price includes the collection of the sample, the genetic testing process, and a comprehensive report detailing the findings. Given the complexity and the specialized nature of the test, the cost reflects the technical expertise and the advanced technology required to accurately diagnose CHIME Syndrome at a genetic level.
Patients and families considering this test are encouraged to discuss it with their healthcare providers to understand its benefits and implications fully. Early diagnosis through the PIGL Gene CHIME Syndrome Genetic Test can be a critical step in managing the condition effectively and improving the quality of life for those affected.
The "IMPAD1 Gene Chondrodysplasia with Joint Dislocations GPAPP Type Genetic Test" is a specialized diagnostic tool offered by DNA Labs UAE, designed to detect mutations in the IMPAD1 gene, which are associated with a rare genetic disorder. This condition, known as chondrodysplasia with joint dislocations, GPAPP type, is characterized by skeletal abnormalities, including short stature, joint dislocations, and other skeletal malformations that affect the individual's quality of life from an early age.
This genetic test is crucial for early diagnosis and management of the condition, allowing for targeted interventions and support to improve the patient's health outcomes. Conducted through a sample of the patient's DNA, the test identifies specific genetic mutations in the IMPAD1 gene that are responsible for the disorder, providing valuable information for families and healthcare providers.
The test is priced at 4400 AED, reflecting the specialized nature of the diagnostic procedure and the advanced technology utilized to achieve accurate results. By opting for this test at DNA Labs UAE, patients and their families can gain insights into the genetic basis of the condition, enabling informed decisions regarding treatment and management, and paving the way for a better understanding of the disorder's implications.
The PTH1R Gene Chondrodysplasia Blomstrand Type Genetic Test is a specialized diagnostic tool designed to identify mutations in the PTH1R gene, which are responsible for Chondrodysplasia Blomstrand Type (BOCD), a rare autosomal recessive skeletal dysplasia. This condition is characterized by advanced bone age, short limbs, and other skeletal abnormalities evident from prenatal development or at birth. The test is crucial for early diagnosis, allowing for appropriate management and counseling for affected families.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, typically through a blood draw, and examining the PTH1R gene for specific mutations known to cause BOCD. The accuracy and reliability of the test make it a valuable resource for clinicians and genetic counselors in the diagnosis and management of this rare condition.
The cost of the PTH1R Gene Chondrodysplasia Blomstrand Type Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the comprehensive analysis and the specialized expertise required to interpret the results accurately. Given the complexity of genetic testing and the rare nature of BOCD, this test is a critical tool in providing affected individuals and their families with the necessary information to understand their condition and make informed health decisions.
The CHM Gene Choroideremia Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to identify mutations in the CHM gene, which are linked to the development of choroideremia. Choroideremia is a rare genetic condition that causes progressive vision loss, typically affecting males due to its X-linked inheritance pattern. This condition leads to the degeneration of the choroid, retinal pigment epithelium, and the photoreceptors.
The test is critical for individuals with a family history of choroideremia, offering them an opportunity for early diagnosis. Early identification of the condition can aid in better management and understanding of the disease progression, and potentially guide treatment decisions in the future. Furthermore, it serves an essential role in genetic counseling, helping families understand the risk of passing the condition to future generations.
Performed at the state-of-the-art facilities of DNA Labs UAE, the test requires a DNA sample, usually collected through a blood draw or cheek swab. The process is meticulous, ensuring accuracy and confidentiality of the genetic information.
The cost of the CHM Gene Choroideremia Genetic Test at DNA Labs UAE is 4400 AED. While the price may seem substantial, the value of the information it provides for affected individuals and their families is significant, offering insights into managing the condition and making informed decisions about family planning.
